A new report finds most health plans are failing to offer their members seamless digital experiences. Members are frustrated by these oftentimes confusing online journeys, a sentiment that could be costing insurers' revenue and customers.
Industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
This engaging panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
The fact that a majority of denied claims are preventable is only one aspect of a much deeper problem. Reworking claims take time, money, and resources. But here's how resource-strapped providers can leverage artificial intelligence to reimagine claims management.
AbbVie drug Skyrizi is now approved for Crohn's disease, making it the first treatment for the disorder that addresses a particular protein associated with inflammation. In other drug decision news, the Rhythm Pharmaceuticals product Imcivree added the rare disease Bardet-Beidl syndrome as a new approved indication.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments